Epigral Limited board approved re-appointment of three Non-Executive Independent Directors for second five-year terms effective May 20, 2026.
The re-appointments of Sanjay Asher, Kanubhai Patel, and Raju Swamy are subject to shareholder approval via postal ballot.
All directors are unrelated to other board members and not debarred from holding office by SEBI or any authority.
The disclosure is made pursuant to SEBI Listing Regulations and Master Circular requirements for board composition changes.